Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,217
Out of 5,072 analysts
358
Total ratings
30.18%
Success rate
-9.17%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $11.74 | +181.09% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.54 | +78.20% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.67 | +221.20% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $4.04 | +48.51% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.25 | +1,180.00% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.54 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $8.45 | +846.75% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.05 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.58 | +458.66% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.09 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.53 | +353.26% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.38 | +291.85% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.19 | +572.27% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $18.55 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.60 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $33.41 | +64.62% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $19.87 | +156.67% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.05 | +38.61% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.55 | +909.01% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $11.44 | +170.98% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.82 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $27.54 | +2,441.76% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $35.88 | -16.39% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.10 | +990.91% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $11.74
Upside: +181.09%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.54
Upside: +78.20%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.67
Upside: +221.20%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $4.04
Upside: +48.51%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.25
Upside: +1,180.00%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $8.45
Upside: +846.75%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.58
Upside: +458.66%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.09
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.53
Upside: +353.26%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.38
Upside: +291.85%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.19
Upside: +572.27%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $18.55
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $33.41
Upside: +64.62%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $19.87
Upside: +156.67%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.05
Upside: +38.61%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.55
Upside: +909.01%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $11.44
Upside: +170.98%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $27.54
Upside: +2,441.76%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $35.88
Upside: -16.39%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.10
Upside: +990.91%